Photo Credit: Marco Verch
FDA Panel Approves Pfizer’s COVID Vaccine for Kids Ages 5-11
An FDA advisory panel Tuesday approved Pfizer’s COVID-19 vaccine for children ages 5 to 11, setting the stage for the kiddie group to start getting jabs as early as next week.
The approval was the first regulatory hurdle for the immunization for the age group.
The federal Food and Drug Administration must now consider formal approval of the shot. If the agency OKs it as expected, the ball then lands in the CDC’s court.
Read More at the New York Post
